(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.41%) $924.25
(0.32%) $0.935
(0.80%) $11.04
(0.18%) $0.801
(-0.32%) $91.87
Live Chart Being Loaded With Signals
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases...
Stats | |
---|---|
Today's Volume | 185 167 |
Average Volume | 570 667 |
Market Cap | 11.63M |
EPS | $0 ( 2024-03-26 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.122 |
ATR14 | $0.0180 (148.76%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-20 | Puretech Health Plc | Buy | 0 | Convertible Note |
2023-06-12 | Puretech Health Plc | Buy | 0 | Convertible Note |
2023-05-26 | Puretech Health Plc | Buy | 43 133 803 | Warrants |
2023-05-26 | Puretech Health Plc | Buy | 0 | Convertible Note |
2023-05-01 | Puretech Health Plc | Buy | 192 307 692 | Warrants |
INSIDER POWER |
---|
99.96 |
Last 86 transactions |
Buy: 269 373 579 | Sell: 26 728 050 |
Volume Correlation
Gelesis Holdings, Inc. Correlation
10 Most Positive Correlations | |
---|---|
TBI | 0.855 |
VFC | 0.849 |
NBHC | 0.848 |
AFG | 0.839 |
AUD | 0.836 |
HP | 0.832 |
COP | 0.827 |
ETRN | 0.825 |
DVN | 0.822 |
BOC | 0.821 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Gelesis Holdings, Inc. Correlation - Currency/Commodity
Gelesis Holdings, Inc. Financials
Annual | 2022 |
Revenue: | $25.77M |
Gross Profit: | $-1.79M (-6.95 %) |
EPS: | $-0.790 |
FY | 2022 |
Revenue: | $25.77M |
Gross Profit: | $-1.79M (-6.95 %) |
EPS: | $-0.790 |
FY | 2021 |
Revenue: | $11.19M |
Gross Profit: | $1.20M (10.75 %) |
EPS: | $-0.0423 |
Financial Reports:
No articles found.
Gelesis Holdings, Inc.
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators